Table 3.
Gene | Description | d 10 | d 21 |
---|---|---|---|
Acta2 | Actin, α 2, smooth muscle | −2.84 | 1.52 |
Bcl2 | B cell leukemia/lymphoma 2 | −3.47 | 1.49* |
Bmp7 | Bone morphogenetic protein 7 | −2.25 | 1.19 |
Cav1 | Caveolin 1, caveolae protein | −2.77 | 1.89* |
Ccl11 | Chemokine (C-C motif) ligand 11 (eotaxin) | −1.41 | 3.75* |
Ccl12 | Chemokine (C-C motif) ligand 12 | −2.29 | 1.49 |
Ccl3 | Chemokine (C-C motif) ligand 3 (Mip1-α) | −2.90 | −1.33 |
Ccr2 | Chemokine (C-C motif) receptor 2 (Mcp1 receptor) | −4.35* | −1.32 |
Col1a2 | Collagen, type I, α 2 | 1.78 | 1.90* |
Ctgf | Connective tissue growth factor | 1.12 | 2.38* |
Cxcr4 | Chemokine (C-X-C motif) receptor 4 | −2.77 | 1.50* |
Dcn | Decorin | −2.26 | −1.35 |
Edn1 | Endothelin 1 | −3.47 | 1.88* |
Egf | Epidermal growth factor | −2.27 | 1.19 |
Eng | Endoglin | −3.49* | 1.49* |
Fasl | Fas ligand (TNF superfamily, member 6) | −3.74 | 2.94* |
Grem1 | Gremlin 1 | −2.88 | 1.15 |
Hgf | Hepatocyte growth factor | −2.19 | −1.33 |
Il13ra2 | Interleukin 13 receptor α 2 | −2.25 | −1.11 |
Il1a | Interleukin 1 α | −4.62* | 2.36* |
Il1b | Interleukin 1 β | −11.06* | 1.19 |
Il4 | Interleukin 4 | −2.21 | 1.15 |
Il5 | Interleukin 5 | −2.19 | −1.09 |
Inhbe | Inhibin β E | −3.55 | −1.69 |
Itga1 | Integrin α 1 | −2.86* | −1.35 |
Itga2 | Integrin α 2 | −2.91 | −1.34 |
Itgb3 | Integrin β 3 | −2.22 | 1.20 |
Itgb5 | Integrin β 5 | −3.47 | −1.68* |
Jun | Jun oncogene | −3.48* | −1.33 |
Lox | Lysyl oxidase | −3.49* | −1.34 |
Mmp13 | Matrix metallopeptidase 13 (interstitial collagenase) | −2.60 | 1.20 |
Mmp14 | Matrix metallopeptidase 14 (membrane-inserted) | −2.26 | −1.34 |
Mmp3 | Matrix metallopeptidase 3 (stromelysin 1) | −7.12* | −3.41* |
Mmp8 | Matrix metallopeptidase 8 (neutrophil collagenase) | −14.61* | 1.49* |
Mmp9 | Matrix metallopeptidase 9 (type IV collagenase) | −5.91* | −1.07 |
Myc | Myelocytomatosis oncogene | −2.31 | 1.50* |
Plat | Plasminogen activator, tissue | −3.65 | 1.88* |
Plau | Plasminogen activator, urokinase | −2.21 | −2.11* |
Serpina1a | Serine (or cysteine) peptidase inhibitor, clade A, member 1A | −2.19 | 2.55* |
Serpine1 | Serine (or cysteine) peptidase inhibitor, clade E, member 1 | −2.91 | −1.08 |
Smad2 | SMAD family member 2 | −2.19 | 1.50 |
Smad6 | SMAD family member 6 | −4.40* | 1.51* |
Smad7 | SMAD family member 7 | −5.52* | 1.17 |
Snai1 | Snail homolog 1 (Drosophila) | −4.42* | 1.50 |
Tgfb1 | Transforming growth factor, β 1 | −2.20 | −1.34 |
Tgfb3 | Transforming growth factor, β 3 | −2.76 | −1.06 |
Tgif1 | TGFB-induced factor homeobox 1 | −2.26 | −2.69* |
Thbs2 | Thrombospondin 2 | −2.18 | 1.50* |
Timp4 | Tissue inhibitor of metalloproteinase 4 | −1.73 | 2.38 |
P < 0.05 for V2O5-treated D2 mice vs. V2O5-treated B6 mice.